WORLDLINE 10.814 € (+5,19 %) EUTELSAT COMMUNIC. 2.499 € (+3,56 %) TOTALENERGIES 65.920 € (-3,10 %) HERIGE 21.100 € (+2,93 %) CAPITAL B 0.425 € (+5,60 %) SAFRAN 349.900 € (+1,42 %) BNP PARIBAS ACT.A 101.160 € (-0,96 %) SOCIETE GENERALE 76.850 € (-0,67 %) 
MAROC TELECOM 8.800 € (-0,68 %) 
PHARMING GROUP 1.199 € (-0,25 %) SANOFI 73.050 € (-2,70 %) PIERRE VACANCES 1.816 € (-0,22 %) RENAULT 26.280 € (+4,78 %) 
SHELL PLC 33.595 € (-1,38 %) DASSAULT SYSTEMES 18.385 € (+3,20 %) WOLTERS KLUWER 57.200 € (+1,35 %) NN GROUP 75.820 € (-1,10 %) 
ARCELORMITTAL SA 52.040 € (-1,25 %) ENGIE 26.550 € (-3,77 %) ASML HOLDING 1 641.600 € (-4,64 %) 
AEGON 7.578 € (+1,88 %) ING GROEP N.V. 27.640 € (-0,11 %) FLOW TRADERS 25.820 € (0,00 %) VINCI 124.300 € (-2,74 %) VIRIDIEN 77.300 € (-7,76 %) VIVENDI SE 2.216 € (+2,59 %) ALTAREA 96.700 € (-1,02 %) BOUYGUES 47.590 € (-2,50 %) ASM INTERNATIONAL 993.000 € (-0,75 %) SCHNEIDER ELECTRIC 276.650 € (-3,07 %) ESSILORLUXOTTICA 173.000 € (+5,46 %) BUREAU VERITAS 26.700 € (-0,30 %) LVMH 481.000 € (-0,64 %) CARREFOUR 15.700 € (-3,38 %) BOLLORE 4.080 € (+0,59 %) GROUPE GUILLIN 22.600 € (0,00 %) Coca-ColaEuropacif 92.600 € (+5,47 %) AIRBUS 198.220 € (+1,89 %) THALES 229.400 € (+2,05 %) CREDIT AGRICOLE 17.480 € (-0,65 %) UNIBAIL-RODAMCO-WE 101.100 € (-1,32 %) PERNOD RICARD 61.980 € (-2,94 %) CAPGEMINI 90.720 € (+3,14 %) EURONEXT 140.900 € (+0,64 %) KERING 245.750 € (-0,63 %) AXA 43.500 € (-0,80 %) PUBLICIS GROUPE SA 84.460 € (+2,10 %) HERMES INTL 1 595.000 € (-0,19 %) L'OREAL 380.350 € (-0,86 %) ORANGE 15.765 € (-4,48 %) DANONE 72.200 € (+0,64 %) STMICROELECTRONICS 62.370 € (-3,29 %) SAINT GOBAIN 78.460 € (-0,88 %) NEXITY 7.825 € (-0,25 %) HEINEKEN 74.480 € (+1,20 %) VALEO 12.635 € (-1,40 %) PHILIPS KON 23.960 € (+0,84 %) RELX 27.680 € (+0,36 %) FUGRO 9.525 € (+0,79 %) ABN AMRO BANK N.V. 37.030 € (-0,40 %) |
21/03/2023 14:00
Watermelon-Sized Tumor Shrinks 75% – Several Weeks After Receiving Tumor-Targeted Immunotherapy and Short-Course Radiation – Without Systemic ChemotherapyLOS ANGELES, CA / ACCESSWIRE / March 21, 2023 / Hebert Schramm MD, Medical Director of Integrative Cancer Centers of America (www.iccahelp.com) announces that a 69 y/o female from Northern California saw her 15-inch metastatic liver tumor shrink 75% in volume, within several weeks after receiving proprietary tumor-targeted immunotherapy and short-course radiation from ICCA's global cancer center in Baja California - minutes away from downtown San Diego, CA.  The patient had been denied treatment at several prestigious northern California cancer centers, because of experiencing chemotherapy-induced cardiotoxicity while undergoing first-line therapy for ovarian cancer 8 years earlier. As these life-threatening tumors in multiple locations continued to grow, the patient began frantically searching the internet for cancer centers that could treat solid tumors without systemic chemotherapy -- knowing fully well systemic chemotherapy could potentially take her life! ICCA accepted the patient, and immediately began administering a treatment plan consisting of non-toxic tumor-targeted immunotherapy, short-course radiation, and an autologous dendritic cell vaccine, which when given together, have been clinically shown to safely and effectively treat metastatic and recurrent tumors without bringing systemic harm to the patient - particularly when potential acute cardiac toxicity was possible. FivePoints Cancer Care is a customized treatment program offering late-stage and metastatic cancer patients cutting edge globally approved, and when indicated, US-approved modalities all within a patient-centric environment - and often unavailable to U.S./Canadian cancer patients. Greg DiRienzo, CEO says ICCA is recognized worldwide for instigating significant reduction, shrinkage, or even full necrosis (tumor death) of aggressive metastatic and recurrent cancers tumors, without damaging surrounding tissues. ICCA treats at first-class treatment centers in Tijuana, Baja California, Mexico, and satellite locations in San Clemente and Los Angeles, California. Integrative Cancer Centers of America is a global cancer center dedicated to restoring hope and restoring life to late-stage and recurrent cancer patients. CONTACT: SOURCE: Integrative Cancer Centers of America View source version on accesswire.com: https://www.accesswire.com/744757/Watermelon-Sized-Tumor-Shrinks-75-Several-Weeks-After-Receiving-Tumor-Targeted-Immunotherapy-and-Short-Course-Radiation-Without-Systemic-Chemotherapy Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière